ATE337789T1 - Pharmazeutische zusammensetzung enthaltend 2,3- alkylcarbonyloxybenzoesäure und ibuprofen - Google Patents

Pharmazeutische zusammensetzung enthaltend 2,3- alkylcarbonyloxybenzoesäure und ibuprofen

Info

Publication number
ATE337789T1
ATE337789T1 AT02009331T AT02009331T ATE337789T1 AT E337789 T1 ATE337789 T1 AT E337789T1 AT 02009331 T AT02009331 T AT 02009331T AT 02009331 T AT02009331 T AT 02009331T AT E337789 T1 ATE337789 T1 AT E337789T1
Authority
AT
Austria
Prior art keywords
ibuprofen
pharmaceutical composition
composition containing
alkylcarbonyloxybenzoic acid
alkylcarbonyloxybenzoic
Prior art date
Application number
AT02009331T
Other languages
English (en)
Inventor
Michael T Flavin
Deanna J Nelson
Julian F Borgia
Gary J Jesmok
Original Assignee
Advanced Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Life Sciences Inc filed Critical Advanced Life Sciences Inc
Application granted granted Critical
Publication of ATE337789T1 publication Critical patent/ATE337789T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02009331T 1994-12-30 1995-12-21 Pharmazeutische zusammensetzung enthaltend 2,3- alkylcarbonyloxybenzoesäure und ibuprofen ATE337789T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/366,885 US5504111A (en) 1994-12-30 1994-12-30 Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome

Publications (1)

Publication Number Publication Date
ATE337789T1 true ATE337789T1 (de) 2006-09-15

Family

ID=23444992

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95944240T ATE235238T1 (de) 1994-12-30 1995-12-21 Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
AT02009331T ATE337789T1 (de) 1994-12-30 1995-12-21 Pharmazeutische zusammensetzung enthaltend 2,3- alkylcarbonyloxybenzoesäure und ibuprofen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95944240T ATE235238T1 (de) 1994-12-30 1995-12-21 Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen

Country Status (7)

Country Link
US (1) US5504111A (de)
EP (2) EP1226821B1 (de)
JP (1) JPH10511953A (de)
AT (2) ATE235238T1 (de)
AU (1) AU4609096A (de)
DE (2) DE69530120T2 (de)
WO (1) WO1996020702A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955496A (en) * 1996-08-13 1999-09-21 The Regents Of The University Of California Dihydroxy-oxy-eicosadienoates
US6174695B1 (en) 1997-08-12 2001-01-16 The Regents Of The University Of California Epoxide hydrolase inhibitor methods
WO2004032825A2 (en) * 2001-11-02 2004-04-22 Advanced Life Sciences, Inc. Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
WO2004010989A1 (en) * 2002-07-25 2004-02-05 Advances Life Sciences, Inc. Use of 2,3 alkylcarbonyloxybenzoic acids, derivatives and analogues therefrom in the treatment of tissue and cellular dysfunction damage and injury in mammals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443476A (en) * 1981-07-20 1984-04-17 The Upjohn Company Treatment of adult respiratory distress syndrome
EP0070714B1 (de) * 1981-07-20 1986-05-07 The Upjohn Company Verwendung von Ibuprofen oder Flurbiprofen zur Herstellung eines Medikaments zur Behandlung von Respiratonsstörungen
US4447451A (en) * 1981-07-20 1984-05-08 The Upjohn Manufacturing Company M Treatment of adult respiratory distress syndrome
US4686100A (en) * 1985-04-02 1987-08-11 The Board Of Trustees Of The Leland Stanford Junior University Method for the treatment of adult respiratory distress syndrome
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
US5198420A (en) * 1989-10-02 1993-03-30 The General Hospital Corporation Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
EP0458536B1 (de) * 1990-05-24 1998-03-18 Zeneca Limited Therapeutisches Mittel zur Vorbeugung und Behandlung des Atemnotsyndroms bei Erwachsenen
JP2925391B2 (ja) * 1992-01-09 1999-07-28 サントリー株式会社 Ａｒｄｓ治療用医薬組成物
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Also Published As

Publication number Publication date
JPH10511953A (ja) 1998-11-17
EP0801563B1 (de) 2003-03-26
EP1226821B1 (de) 2006-08-30
DE69530120T2 (de) 2004-02-05
EP1226821A3 (de) 2003-09-17
DE69535210D1 (de) 2006-10-12
AU4609096A (en) 1996-07-24
WO1996020702A1 (en) 1996-07-11
DE69530120D1 (de) 2003-04-30
ATE235238T1 (de) 2003-04-15
DE69535210T2 (de) 2007-08-02
EP1226821A2 (de) 2002-07-31
EP0801563A1 (de) 1997-10-22
US5504111A (en) 1996-04-02

Similar Documents

Publication Publication Date Title
DE69103206D1 (de) Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel.
NZ229787A (en) Amino ether diphosphonic acid derivatives and pharmaceutical compositions
DE59105815D1 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
HUT67028A (en) Indole derivatives, pharmeceutical compositions comprising them and process for their production
DE68922478D1 (de) Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69116237D1 (de) Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE69535210D1 (de) Pharmazeutische Zusammensetzung enthaltend 2,3-Alkylcarbonyloxybenzoesäure und Ibuprofen
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK0505180T3 (da) Farmaceutisk præparat med højt indhold af ibuprofenlysinat
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
HU9202641D0 (en) Method for producing methano-anthracene derivatives and pharmaceutical preparatives containing said compounds as active substance
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
HU900717D0 (en) Process for preparation of 3-pyroglutamyl-thyazolidine-4-carboxylic acid derivatives and pharmaceutical compositions containing that compounds
DE68905361D1 (de) Trienische derivate mit chromenischer struktur, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
IL98199A (en) Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties